Amgen gets FDA approval for its inflammatory diseases treatment Wezlana By: MarketWatch October 31, 2023 at 18:22 PM EDT Amgen has received approval from the U.S. Food and Drug Administration for Wezlana, its treatment for multiple inflammatory diseases. Read More >> Related Stocks: Amgen
